
DRUGS MADE IN AMERICA ACQ-RT
DMIIR · NASDAQ
更新於 2026-10-13 13:30:49
- 今日最高
- --
- 今日最低
- --
K線圖趨勢,實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $0.05
- 昨天收盤價
- $0.07
- 成交量
- 164.27K
- 市值
- $649.1M
- 市盈率(P/E)
- 49.85X
- 每股收益(EPS)
- $0.80
昨天價格區間
52週價格區間
公司概況
- 板塊
- --
- 行業
- N/A
- 子行業
- --
- 總部
- 420 LEXINGTON AVENUE, NEW YORK, NY, UNITED STATES, 10170
- 國家
- US
- 上市日期
- 2025-09-25
- 財年截止
- --
- 流通股數
- 63.7M
- CIK
- --
- 官方網址
- --
Drugs Made In America Acquisition II Corp. Right (DMIIR) is a special purpose acquisition company (SPAC) strategically focused on merging with innovative pharmaceutical firms dedicated to bolstering domestic drug manufacturing capabilities. Led by an experienced management team, DMIIR is positioned to address the growing demand for affordable and accessible medications within the U.S. healthcare landscape. The company seeks to execute targeted acquisitions that not only enhance shareholder value but also contribute to the strengthening of the essential healthcare infrastructure in America, ultimately fostering a more resilient and self-sufficient pharmaceutical ecosystem.
財務指標
--
常見問題
風險提示
股價可能大幅波動,短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考,不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。